Clinical Trials – Impact of COVID-19 and Long COVID
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Long Covid Clinical Trials Analysis Report Overview
This report provides an overview of global COVID-19 clinical trials, long COVID clinical trials, and trialsĀ disrupted by COVID-19.
Scope
The clinical trials data used for these analyses were extracted from GlobalDataās Clinical Trials Database. The data was captured in the database as of April 12, 2023. The data was analyzed and segmented by COVID-19 trials, COVID-19 trials for vaccines and therapeutics, and long COVID trials. An analysis was also completed on non-COVID trials impacted due to the pandemic.
Reasons to Buy
Trends of COVID-19 trials through the years
Comparison of trials by phase, sponsor type and status
Geographic analysis
Focus on top sponsors for vaccine and therapeutic trials
Long COVID analysis
COVID-19 impact on trials
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customerās requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.